APA (7th ed.) Citation

Schirmer, M., Lüske, C. M., Roppel, S., Schaudinn, A., Zimmer, C., Pflüger, R., . . . Ghadimi, B. M. (2016). Relevance of Sp binding site polymorphism in WWOX for treatment outcome in pancreatic cancer. Journal of the National Cancer Institute, 108(5), . https://doi.org/10.1093/jnci/djv387

Chicago Style (17th ed.) Citation

Schirmer, Markus, et al. "Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer." Journal of the National Cancer Institute 108, no. 5 (2016). https://doi.org/10.1093/jnci/djv387.

MLA (9th ed.) Citation

Schirmer, Markus, et al. "Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer." Journal of the National Cancer Institute, vol. 108, no. 5, 2016, https://doi.org/10.1093/jnci/djv387.